Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,409.50 +74.18 0.48%
S&P 500 1,672.29 +6.00 0.36%
Nasdaq 3,507.22 +10.78 0.31%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: BM&FBOVESPA
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

BIOM4:BZ

7.800 BRL 0.190 2.50%

As of 10:25:11 ET on 05/21/2013.

Company Profile for Biomm SA (BIOM4)

Biomm SA is a biotechnology company. The Company produces human and swine insulins using recombinant DNA techniques.

Contact Information

Biomm SA

Praca Carlos Chagas 49
8 Andar Santo Agostinho
Belo Horizonte, MG 30170-020
Brazil
Phone: 55-31-3292-5003
Fax: 55-31-3291-9212

Key Executives for Biomm SA (BIOM4)

Guilherme Caldas EmrichChairmanFrancisco Carlos Marques De FreitasPres/CEO/Investor Relations
Luciano VilelaOfficer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil